SHPW yields 666.67% · JNJ yields 2.13%● Live data
📍 SHPW pulled ahead of the other in Year 1
Combined, SHPW + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SHPW + JNJ for your $10,000?
Shapeways Holdings, Inc. facilitates the design, manufacture, and sale of 3D printed products in the United States, Europe, and internationally. The company offers an end-to-end digital manufacturing platform on which the users can transform digital designs into physical products under the Otto brand. It provides additive manufacturing services, such as 3D printing, rapid prototyping, and design services; and traditional manufacturing services, including injection molding, sheet metal, urethane and vacuum casting, CNC machining, and machine tooling. It also offers selective laser sintering materials, which include nylon 12, thermoplastic polyurethane, nylon 11, nylon 6 mineral filled, and polypropylene; binder jetting materials consisting of stainless steel and sandstone; multi-jet fusion materials; stereolithography materials, such as accura 60, accura xtreme, and accura xtreme white 200; selective laser melting material, including aluminum; material jetting materials, such as fine detail plastic, multi-color polyjet, and high definition full color; and wax casting materials comprising copper, platinum, gold, silver, bronze, brass, rhodium plated brass, and gold plated brass. The company serves the medical, consumer, robotics, architecture, aerospace, gaming, drones, education, and jewelry industries. Shapeways Holdings, Inc. was founded in 2008 and is based in Long Island City, New York.
Full SHPW Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.